PharmaMar
PharmaMar is a biopharmaceutical company focused on the research and development of new oncology treatments, whose mission is to improve the healthcare of patients with our innovative medicines. The Company is inspired by the sea, driven by science, and motivated by patients. It is the world leader in marine medicinal discovery and development. PharmaMar commercializes Yondelis in Europe and Zepzelca in Switzerland by itself, as well as outside Europe with different partners for Yondelis, Zepzelca and Aplidin. In addition, it has a pipeline of drug candidates and a robust R&D oncology program.